Latest News
-
Tuesday - September 22, 2009
Leading-edge medical research and development:
Bayer researchers nominated for the “Deutscher Zukunftspreis” awarded by the German Federal President
Development of the novel anticoagulant rivaroxaban commended / Three research and development teams on shortlist
-
Tuesday - September 22, 2009
Contribution to the fight against tropical diseases
Bayer to supply WHO with a product for the combination therapy of African sleeping sickness
New combination therapy added to the WHO's Essential Drug List
-
Tuesday - September 22, 2009
Once again included in the Carbon Disclosure Leadership Index
Bayer honored as world’s best company in climate protection
Index organizer Dickinson: “Listed companies are the best placed to prosper in a low carbon economy of the future” / Bayer CEO Wenning: “Top position is high praise for our strategic alignment” / Investors and analysts specifically interested in companies' climate strategies
-
Tuesday - September 22, 2009
Results of a Phase II study in Renal Cell Carcinoma (RCC):
Bayer’s Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
Presentation of complete results at joint 15th ECCO and 34th ESMO Multidisciplinary Congress / Confirmation of topline data presented at ASCO 2009
-
Thursday - September 17, 2009
Bayer CropScience AG:
Annual Press Conference 2009
-
Thursday - September 17, 2009
Joint 15th ECCO and 34th ESMO Multidisciplinary Congress:
Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
Marketed Products and Pipeline Compounds Highlighted at Presentation Sessions
-
Tuesday - September 15, 2009
Bayer Supervisory Board decides company’s future management line-up:
Dr. Marijn E. Dekkers to be new CEO of Bayer from October 1, 2010
Werner Wenning extends his contract by eight months / CFO Klaus Kühn to retire on April 30, 2010 / Werner Baumann to be new CFO / BHC CEO Arthur J. Higgins to leave Bayer at his own request
-
Tuesday - September 15, 2009
Bayer MaterialScience signs supply and cooperation contract with Hirtenberger PROSAFE Safety Technology
Baytubes® carbon nanotubes to be used in innovative safety technology to prevent explosions in fuel tanks
-
Thursday - September 10, 2009
European Multiple Sclerosis Congress ECTRIMS:
Recent Research Supports the Importance of Starting Treatment Early in Patients with Multiple Sclerosis (MS)
New data show impact of hidden symptoms in early MS
-
Thursday - September 10, 2009
New data presented at European Multiple Sclerosis Congress ECTRIMS:
Betaferon® may play a role in the protection of brain tissue
-
Tuesday - September 8, 2009
Support that works:
Bayer Foundation launches Aspirin Social Award
Dr. Pott, member of the Bayer Board of Management: “We want to reward specific projects and recognize the importance of innovative social work in the health sector” / Closing date for entries is November 30, 2009 / Ideas from the general public increase prize money / Anyone can rate entries online
-
Monday - September 7, 2009
Expansion at Monheim site completed:
Bayer CropScience invests EUR 4.9 million in compound logistics
New logistics system for crop protection research / Collection contains some 2.2 million chemical substances
-
Friday - September 4, 2009
Bayer again included in the Dow Jones Sustainability World Index:
Bayer remains “best in class” in sustainability
Significance of sustainable investment is continuing to rise
-
Friday - September 4, 2009
German polyurethanes systems house of Bayer MaterialScience renamed BaySystems GmbH & Co. KG
-
Friday - September 4, 2009
Mastering the challenge
Conquering the summit unaided
Diabetic Geri Winkler plans to scale Cho Oyu without the help of supplemental oxygen
-
Thursday - September 3, 2009
Development of new seed products:
Bayer CropScience and Precision BioSciences Inc. collaborate to create site-specific genome modifications in plants
-
Thursday - September 3, 2009
Bayer CropScience and The Greenery sign global cooperation agreement
Global expansion of Food Chain Partnership projects for the sustainable production of high-quality fruits and vegetables
-
Thursday - September 3, 2009
Bayer and Algeta Enter Global Agreement for Development and Commercialization of Treatment for Bone Metastases in Cancer Patients
Phase III compound represents potential therapy for life-threatening condition
-
Wednesday - September 2, 2009
Bayer Acquires Two Prescription Dermatology Product Lines from SkinMedica in the U.S.
Bayer subsidiary Intendis expands presence in the U.S. / Asset purchase agreement signed for marketed prescription products Desonate® and NeoBenz® Micro
-
Tuesday - September 1, 2009
Strengthening cotton-research:
Bayer CropScience and Performance Plants Inc. sign license agreement on drought-tolerant cotton
Search
Publications
Stockholders' Newsletter
Annual Report
Sustainable Development Report
The Bayer Climate Program
research – The Bayer Scientific Magazine
Publications Overview
Newsletter
EventsFriday, February 26, 2010
Annual Report 2009 / Financial News Conference Full Year 2009
Contact: Günter Forneck
Additional Press Events
Investor Relations Events
Sport Events
BayKomm Events
Download Center - Selection
